The 21 references in paper L. Solomatina V., Yu. Zhuravleva A., E. Gusev Yu., Л. Соломатина В., Ю. Журавлева А., Е. Гусев Ю. (2009) “КОНЦЕПЦИИ MIA-СИНДРОМА И СИСТЕМНОГО ВОСПАЛЕНИЯ ПРИ ТЕРМИНАЛЬНОЙ ПОЧЕЧНОЙ НЕДОСТАТОЧНОСТИ // CONCEPT MIA-SYNDROME AND SYSTEMIC INFLAMMATION IN END STAGE RENAL DISEASE” / spz:neicon:nefr:y:2009:i:4:p:64-69

1
Renal Data System. USRDS 2003 annual data report: atlas of end-stage renal disease in the United States. Bethesda: National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2003
(check this in PDF content)
2
Locatelli F, Marcelli D, Conte F et al. Cardiovascular disease in chronic renal failure: the challenge continues. Registro Lambardo Dialisi e Trapianto. Nephrol Dial Transplant 2000; 15 [suppl 5]: 69-80
(check this in PDF content)
3
Foley RN, Parfrey PS, Sarnack MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32 [suppl 3]: 112-119
(check this in PDF content)
4
Shah NR, Dumler F. Hypoalbuminemia - a marker of cardiovascular disease in patients of chronic kidney disease stage II-IV. Int J Med Sci 2008; 5(6): 366-370
(check this in PDF content)
5
Qureshi A, Alvestrand A, Divino-Filho J et al. Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. J Am Soc Nephrol 2002; 13: S28-S36
(check this in PDF content)
6
Porazko T, Kuzniar J, Kusztal M et al. IL-8 is involved in vascular injury in end-stage renal disease patients. Nephrol Dial Transplant 2009; 24(2): 586-596
(check this in PDF content)
7
Stenvinkel P, Alverstrand A. Inflammation in end-stage renal disease: sources, consequences, and therapy. Semin Dial 2002; 15: 329-337
(check this in PDF content)
8
Yao Q, Axellson J, Heimburger O et al. Systemic inflammation in dialysis patients with end-stage renal disease: causes and consequences. Minerva Urol Nephrol 2004; 56: 237­ 248
(check this in PDF content)
9
Wanner C, Metzger T. C-reactive protein-a marker for all-cause and cardiovascular mortality in haemodialysis patients. Nephrol Dial Transplant 2002; 17[suppl 8]: 29-32
(check this in PDF content)
10
Foley RN, Parfrey PS, Harnett JD et al. Hypoalbuminemia, cardic morbidity and mortality in end-stage renal disease. J Am Soc Nephrol 1996; 7: 728-736
(check this in PDF content)
11
Ardag I, Yilmaz Y, Kahvecioglu S et al. Clinical value of the malnutrition-inflammation-atherosclerosis syndrome for long-term predictor of cardiovascular mortality in patients with end-stage renal disease: a 5-year prospective study. Nephron Clin Pract 2008; 108 (2): 99-105
(check this in PDF content)
12
Honda H, Qureshi AR, Heimburger O et al. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis 2006; 47(1):139-148
(check this in PDF content)
13
Dhingra R, Gona P, Nam B-N et al. C-reactive protein, inflammatory conditions and cardiovascular disease risk. Am J Med 2007; 120(12):1054-1062
(check this in PDF content)
14
Гусев ЕЮ, Черешнев ВА, Юрченко ЛН. Системное воспаление с позиции типового патологического процесса. Цитокины и воспаление 2007; 6 (4): 9-21
(check this in PDF content)
15
Гусев ЕЮ, Юрченко ЛН, Черешнев ВА и др. Методо­ логия изучения системного воспаления. Цитокины и воспа­ ление 2008; 7 (1): 15-23
(check this in PDF content)
16
Гусев ЕЮ, Соломатина ЛВ, Журавлёва ЮА и др. Си­ стемная воспалительная реакция у больных с терминаль­ ной хронической почечной недостаточностью. Нефрология и диализ 2008; 10 (3-4): 248-253
(check this in PDF content)
17
Iseki K, Kawazoe N, Fukiyama K. Serum albumin is a strong predictor of death in chronic dialysis patients. Kidney Int 1993; 44(1):115-119
(check this in PDF content)
18
Beddhu S, Kaysen GA, Yan G et al. Association of serum albumin and atherosclerosis in chronic hemodialysis patients. Am J Kidney Dis 2002; 40: 721-727
(check this in PDF content)
19
Owen WFJr, Lew NL, Liu Y et al. The reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 1993; 329:1001-1006
(check this in PDF content)
20
Kalantar-Zadeh K, Kilpatrick RD, Kuwae et al. Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction. Nephrol Dial Transplant 2005; 20: 1880-1888
(check this in PDF content)
21
Лейдерман ИН, Руднов ВА, Клейн АВ и др. Синдром гиперметаболизма - универсальное звено патогенеза кри­ тических состояний. Вестник интенсивной терапии 1997; (3): 17-23 Поступила в редакцию 8.09.2009 г.
(check this in PDF content)